Perspective Therapeutics, Inc. (CATX)

Perspective Therapeutics Revenue

Perspective Therapeutics had revenue of $76.00K in the quarter ending March 31, 2026, a decrease of -77.78%. This brings the company's revenue in the last twelve months to $618.00K, down -57.99% year-over-year. In the year 2025, Perspective Therapeutics had annual revenue of $884.00K, down -39.20%.

• Revenue (ttm): $618.00K
• Revenue Growth: -57.99%
• P/S Ratio: 786.14
• Revenue / Employee: $3,723
• Employees: 166
• Market Cap: 482.42M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	884.00K	-570.00K	-39.20%
Dec 31, 2024	1.45M	20.00K	1.39%
Dec 31, 2023	1.43M	-	-
Dec 31, 2022	-	-	-
Jun 30, 2022	-	-	-
Jun 30, 2021	10.05M	373.00K	3.85%
Jun 30, 2020	9.68M	2.37M	32.35%
Jun 30, 2019	7.31M	1.39M	23.48%
Jun 30, 2018	5.92M	1.16M	24.41%
Jun 30, 2017	4.76M	-8.00K	-0.17%
Jun 30, 2016	4.77M	163.00K	3.54%
Jun 30, 2015	4.61M	386.84K	9.17%
Jun 30, 2014	4.22M	-306.07K	-6.76%
Jun 30, 2013	4.53M	-545.86K	-10.76%
Jun 30, 2012	5.07M	-167.88K	-3.20%
Jun 30, 2011	5.24M	-47.11K	-0.89%
Jun 30, 2010	5.29M	-131.74K	-2.43%
Jun 30, 2009	5.42M	-1.74M	-24.32%
Jun 30, 2008	7.16M	1.42M	24.76%
Jun 30, 2007	5.74M	-	-

Data Source: Fiscal.ai Last updated: May 11, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 22, 2026

Data Sources Report a data error